Navigation Neurocentre Magendie - U1215 par Etablissement "CNRS"
Voici les éléments 1-20 de 58
-
Place des biomarqueurs dans la renutrition des patients ayant une infection grave à Covid-19 : discussion autour d’un cas clinique
(Annales de Biologie Clinique. vol. 80, n° 1, pp. 15-27, 2022-02)Article de revue -
Striatopallidal cannabinoid type-1 receptors mediate amphetamine-induced sensitization
(2023-10)Document de travail - Pré-publicationLibre accès -
Camkiiβ in neuronal development and plasticity: An emerging candidate in brain diseases
(International Journal of Molecular Sciences. vol. 21, n° 19, pp. 1-15, 2020-10-01)Article de revueLibre accès -
Effect of cognitive rehabilitation on neuropsychological and semiecological testing and on daily cognitive functioning in multiple sclerosis: The REACTIV randomized controlled study
(2020-08-15)Document de travail - Pré-publicationLibre accès -
Structural progression of Alzheimer's disease over decades: The MRI staging scheme
(Brain Communications. vol. 4, n° 3, 2022-04-28)Article de revueLibre accès -
Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment
(Neurology(R) neuroimmunology & neuroinflammation. vol. 10, n° 6, 2023-09-22)Article de revueLibre accès -
Lifespan neurodegeneration of the human brain in multiple sclerosis
(Human Brain Mapping. vol. 44, n° 17, pp. 5602-5611, 2023-03-14)Article de revueLibre accès -
Hippocampal-amygdalo-ventricular atrophy score: Alzheimer disease detection using normative and pathological lifespan models.
(Human Brain Mapping. vol. 43, n° 10, pp. 3270-3282, 2022-07)Article de revueLibre accès -
High B-value diffusion tensor imaging for early detection of hippocampal microstructural alteration in a mouse model of multiple sclerosis
(Scientific Reports. vol. 12, n° 1, pp. 12008, 2022-07-14)Article de revueLibre accès -
GRK2‐ Targeted Knockdown as Therapy for Multiple System Atrophy
(Movement Disorders. vol. 38, n° 7, pp. 1336-1340, 2023-07)Article de revueLibre accès -
Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
(Neurology. vol. 101, n° 4, pp. E438-E450, 2023-07-25)Article de revue -
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD.
(Cell. vol. 148, n° 5, pp. 1039-50, 2012-03-02)Article de revueLibre accès -
Differential vulnerability of thalamic nuclei in multiple sclerosis
(Multiple Sclerosis Journal, 2022-08-12)Article de revueLibre accès -
DeepLesionBrain: Towards a broader deep-learning generalization for multiple sclerosis lesion segmentation
(2022-06-13)Document de travail - Pré-publicationLibre accès -
Validation of a Denoising Method Using Deep Learning-Based Reconstruction to Quantify Multiple Sclerosis Lesion Load on Fast FLAIR Imaging.
(American Journal of Neuroradiology. vol. 43, n° 8, pp. 1099-1106, 2022-07-28)Article de revueLibre accès -
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
(Nature Medicine. vol. 29, n° 6, pp. 1487-1499, 2023-06-01)Article de revueLibre accès -
NMDARs, coincidence detectors of astrocytic and neuronal activities
(International journal of molecular sciences. vol. 22, n° 14, 2021-07-06)Article de revueLibre accès -
Severity of Small Vessel Disease Biomarkers Reduces the Magnitude of Cognitive Recovery after Ischemic Stroke
(Cerebrovascular Diseases. vol. 50, n° 4, pp. 456-463, 2021-04-07)Article de revue -
Astrocytic IP3Rs: Beyond IP3R2
(Frontiers in Cellular Neuroscience. vol. 15, 2021-07-30)Article de revueLibre accès -
Normal-Appearing White Matter Deteriorates over the Year After an Ischemic Stroke and Is Associated with Global Cognition
(Translational stroke research./Transl Stroke Res, 2022-01-17)Article de revueLibre accès